Alternative splicing of RAGE: Roles in biology and disease

Frontiers in Bioscience

Volumn 16, Issue 7, 2011, Pages 2756-2770

  Kalea, Anastasia Z ^a   Schmidt, Ann Marie ^b   Hudson, Barry I ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Advanced Glycation End products; Alternative splicing; mRNA; Receptors; Review

Indexed keywords

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; LIGAND; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PROMOTER REGION; PROTEIN TERTIARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; ANIMALS; HUMANS; LIGANDS; MODELS, BIOLOGICAL; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 79959567198     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3884     Document Type: Article

References (101)

1. S. Stamm, S. Ben-Ari, I. Rafalska, Y. Tang, Z. Zhang, D. Toiber, T. A. Thanaraj, and H. Soreq. Function of alternative splicing. Gene, 344( 1-20 (2005) (Pubitemid 40126788)
2. L. F. Lareau, R. E. Green, R. S. Bhatnagar, and S. E. Brenner. The evolving roles of alternative splicing. Curr Opin Struct Biol, 14(3), 273-82 (2004) (Pubitemid 38749054)
3. E. S. Lander, L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody, J. Baldwin, K. Devon, K. Dewar, M. Doyle, W. FitzHugh, R. Funke, D. Gage, K. Harris, A. Heaford, J. Howland, L. Kann, J. Lehoczky, R. LeVine, P. McEwan, K. McKernan, J. Meldrim, J. P. Mesirov, C. Miranda, W. Morris, J. Naylor, C. Raymond, M. Rosetti, R. Santos, A. Sheridan, C. Sougnez, N. Stange-Thomann, N. Stojanovic, A. Subramanian, D. Wyman, J. Rogers, J. Sulston, R. Ainscough, S. Beck, D. Bentley, J. Burton, C. Clee, N. Carter, A. Coulson, R. Deadman, P. Deloukas, A. Dunham, I. Dunham, R. Durbin, L. French, D. Grafham, S. Gregory, T. Hubbard, S. Humphray, A. Hunt, M. Jones, C. Lloyd, A. McMurray, L. Matthews, S. Mercer, S. Milne, J. C. Mullikin, A. Mungall, R. Plumb, M. Ross, R. Shownkeen, S. Sims, R. H. Waterston, R. K. Wilson, L. W. Hillier, J. D. McPherson, M. A. Marra, E. R. Mardis, L. A. Fulton, A. T. Chinwalla, K. H. Pepin, W. R. Gish, S. L. Chissoe, M. C. Wendl, K. D. Delehaunty, T. L. Miner, A. Delehaunty, J. B. Kramer, L. L. Cook, R. S. Fulton, D. L. Johnson, P. J. Minx, S. W. Clifton, T. Hawkins, E. Branscomb, P. Predki, P. Richardson, S. Wenning, T. Slezak, N. Doggett, J. F. Cheng, A. Olsen, S. Lucas, C. Elkin, E. Uberbacher, M. Frazier, R. A. Gibbs, D. M. Muzny, S. E. Scherer, J. B. Bouck, E. J. Sodergren, K. C. Worley, C. M. Rives, J. H. Gorrell, M. L. Metzker, S. L. Naylor, R. S. Kucherlapati, D. L. Nelson, G. M. Weinstock, Y. Sakaki, A. Fujiyama, M. Hattori, T. Yada, A. Toyoda, T. Itoh, C. Kawagoe, H. Watanabe, Y. Totoki, T. Taylor, J. Weissenbach, R. Heilig, W. Saurin, F. Artiguenave, P. Brottier, T. Bruls, E. Pelletier, C. Robert, P. Wincker, D. R. Smith, L. Doucette-Stamm, M. Rubenfield, K. Weinstock, H. M. Lee, J. Dubois, A. Rosenthal, M. Platzer, G. Nyakatura, S. Taudien, A. Rump, H. Yang, J. Yu, J. Wang, G. Huang, J. Gu, L. Hood, L. Rowen, A. Madan, S. Qin, R. W. Davis, N. A. Federspiel, A. P. Abola, M. J. Proctor, R. M. Myers, J. Schmutz, M. Dickson, J. Grimwood, D. R. Cox, M. V. Olson, R. Kaul, C. Raymond, N. Shimizu, K. Kawasaki, S. Minoshima, G. A. Evans, M. Athanasiou, R. Schultz, B. A. Roe, F. Chen, H. Pan, J. Ramser, H. Lehrach, R. Reinhardt, W. R. McCombie, B. M. de la, N. Dedhia, H. Blocker, K. Hornischer, G. Nordsiek, R. Agarwala, L. Aravind, J. A. Bailey, A. Bateman, S. Batzoglou, E. Birney, P. Bork, D. G. Brown, C. B. Burge, L. Cerutti, H. C. Chen, D. Church, M. Clamp, R. R. Copley, T. Doerks, S. R. Eddy, E. E. Eichler, T. S. Furey, J. Galagan, J. G. Gilbert, C. Harmon, Y. Hayashizaki, D. Haussler, H. Hermjakob, K. Hokamp, W. Jang, L. S. Johnson, T. A. Jones, S. Kasif, A. Kaspryzk, S. Kennedy, W. J. Kent, P. Kitts, E. V. Koonin, I. Korf, D. Kulp, D. Lancet, T. M. Lowe, A. McLysaght, T. Mikkelsen, J. V. Moran, N. Mulder, V. J. Pollara, C. P. Ponting, G. Schuler, J. Schultz, G. Slater, A. F. Smit, E. Stupka, J. Szustakowski, D. Thierry-Mieg, J. Thierry-Mieg, L. Wagner, J. Wallis, R. Wheeler, A. Williams, Y. I. Wolf, K. H. Wolfe, S. P. Yang, R. F. Yeh, F. Collins, M. S. Guyer, J. Peterson, A. Felsenfeld, K. A. Wetterstrand, A. Patrinos, M. J. Morgan, J. Szustakowki, J. P. de, J. J. Catanese, K. Osoegawa, H. Shizuya, and S. Choi. Initial sequencing and analysis of the human genome. Nature, 409(6822), 860-921 (2001) (Pubitemid 32165345)
4. A. J. Ward and T. A. Cooper. The pathobiology of splicing. J Pathol, 220(2), 152-63 (2010)
5. A. M. Schmidt, M. Vianna, M. Gerlach, J. Brett, J. Ryan, J. Kao, C. Esposito, H. Hegarty, W. Hurley, M. Clauss, F. Wang, Y. C. E. Pan, T. C. Tsang, and D. Stern. Isolation and characterisation of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial surface. J Biol Chem, 267(21), 14987-97 (1992)
6. M. Neeper, A. M. Schmidt, J. Brett, S. D. Yan, F. Wang, Y. C. P. Pan, K. Elliston, D. Stern, and A. Shaw. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem, 267(21), 14998-5004 (1992)
7. T. Chavakis, A. Bierhaus, N. Al-Fakhri, D. Schneider, S. Witte, T. Linn, M. Nagashima, J. Morser, B. Arnold, K. T. Preissner, and P. P. Nawroth. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med, 198(10), 1507-15 (2003) (Pubitemid 37467165)
8. M. A. Hofmann, S. Drury, C. F. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, M. F. Neurath, T. Slattery, D. Beach, J. McClary, M. Nagashima, J. Morser, D. Stern, and A. M. Schmidt. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for s100/calgranulin polypeptides. Cell, 97(889-901 (1999) (Pubitemid 29375048)
9. T. Arumugam, D. M. Simeone, A. M. Schmidt, and C. D. Logsdon. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem, 279(7), 5059-65 (2004) (Pubitemid 38220521)
10. S. Ghavami, I. Rashedi, B. M. Dattilo, M. Eshraghi, W. J. Chazin, M. Hashemi, S. Wesselborg, C. Kerkhoff, and M. Los. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol, 83(6), 1484-92 (2008) (Pubitemid 351960330)
11. E. Leclerc, G. Fritz, M. Weibel, C. W. Heizmann, and A. Galichet. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem, 282(43), 31317-31 (2007) (Pubitemid 350044892)
12. J. V. Valencia, M. Mone, J. Zhang, M. Weetall, F. P. Buxton, and T. E. Hughes. Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA. Diabetes, 53(3), 743-51 (2004) (Pubitemid 38270645)
13. O. Hori, J. Brett, T. Slattery, R. Cao, J. Zhang, J. X. Chen, M. Nagashima, E. R. Lundh, S. Vijay, D. Nitecki, J. Morser, D. Stern, and A. M. Schmidt. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J Biol Chem, 270(43), 25752-61 (1995)
14. S. D. Yan, X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern, and A. M. Schmidt. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature, 382(6593), 685-91 (1996) (Pubitemid 26282167)
15. J. Brett, A. M. Schmidt, S. D. Yan, Y. S. Zou, E. Weidman, D. Pinsky, R. Nowygrod, M. Neeper, C. Przysiecki, A. Shaw, A. Migheli, and D. Stern. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol, 143(6), 1699-712 (1993) (Pubitemid 24058273)
16. T. M. Wendt, N. Tanji, J. Guo, T. R. Kislinger, W. Qu, Y. Lu, L. G. Bucciarelli, L. L. Rong, B. Moser, G. S. Markowitz, G. Stein, A. Bierhaus, B. Liliensiek, B. Arnold, P. P. Nawroth, D. M. Stern, V. D. D'Agati, and A. M. Schmidt. RAGE Drives the Development of Glomerulosclerosis and Implicates Podocyte Activation in the Pathogenesis of Diabetic Nephropathy. Am J Pathol, 162( 1123-37 (2003) (Pubitemid 36350658)
17. E. Harja, D. X. Bu, B. I. Hudson, J. S. Chang, X. Shen, K. Hallam, A. Z. Kalea, Y. Lu, R. H. Rosario, S. Oruganti, Z. Nikolla, D. Belov, E. Lalla, R. Ramasamy, S. F. Yan, and A. M. Schmidt. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE- /- mice. J Clin Invest, 118(1), 183-94 (2008)
18. N. Demling, C. Ehrhardt, M. Kasper, M. Laue, L. Knels, and E. P. Rieber. Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells. Cell Tissue Res, 323(3), 475-88 (2006) (Pubitemid 43228103)
19. B. I. Hudson, A. M. Carter, E. Harja, A. Z. Kalea, M. Arriero, H. Yang, P. J. Grant, and A. M. Schmidt. Identification, classification, and expression of RAGE gene splice variants. FASEB J, 22( 1572-80 (2008) (Pubitemid 351656797)
20. N. Tanji, G. S. Markowitz, C. F. Fu, T. Kislinger, A. Taguchi, M. Pischetsrieder, D. M. Stern, A. M. Schmidt, and V. D'Agati. Expression of Advanced Glycation End Products and Their Cellular Receptor RAGE in DiabeticNephropathy and Nondiabetic Renal Disease. J Am Soc Nephrol, 11(9), 1656-66 (2000)
21. U. Ritthaler, Y. Deng, Y. Zhang, J. Greten, M. Abel, B. Sido, J. Allenberg, G. Otto, H. Roth, A. Bierhaus, R. Ziegler, A. M. Schmidt, R. Waldherr, P. Wahl, D. M. Stern, and P. P. Nawroth. Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol, 146(3), 688-94 (1995)
22. T. Kislinger, C. Fu, C. Huber, W. Qu, A. Taguchi, S. D. Yan, M. A. Hofmann, S. F. Yan, M. Pischetsrieder, D. Stern, and A. M. Schmidt. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem, 274( 31740-9 (1999)
23. B. M. Dattilo, G. Fritz, E. Leclerc, C. W. Kooi, C. W. Heizmann, and W. J. Chazin. The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry, 46(23), 6957-70 (2007) (Pubitemid 46906424)
24. T. Sakaguchi, S. F. Yan, S. D. Yan, D. Belov, L. L. Rong, M. Sousa, M. Andrassy, S. P. Marso, S. Duda, B. Arnold, B. Liliensiek, P. P. Nawroth, D. M. Stern, A. M. Schmidt, and Y. Naka. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest, 111(7), 959-72 (2003) (Pubitemid 36397472)
25. T. Kislinger, N. Tanji, T. Wendt, W. Qu, Y. Lu, L. J. Ferran, A. Taguchi, K. Olson, M. T. Goova, M. A. Hofmann, G. Cataldegirmen, V. D'Agati, M. Pischetsrieder, D. M. Stern, and A. M. Schmidt. Receptor for Advanced Glycation End Products Mediates Inflammation and Enhanced Expression of Tissue Factor in Vasculature of Diabetic Apolipoprotein Enull Mice. Arterioscler Thromb Vasc Biol, 21(6), 905-10 (2001) (Pubitemid 34168644)
26. H. M. Lander, J. M. Tauras, J. S. Ogiste, O. Hori, R. A. Moss, and A. M. Schmidt. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem, 272( 17810-4 (1997) (Pubitemid 27311222)
27. H. J. Huttunen, C. Fages, and H. Rauvala. Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-kappa B Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways. J Biol Chem, 274(28), 19919-24 (1999)
28. C. H. Yeh, L. Sturgis, J. Haidacher, X. N. Zhang, S. J. Sherwood, R. J. Bjercke, O. Juhasz, M. T. Crow, R. G. Tilton, and L. Denner. Requirement for p38 and p44/p42 mitogenactivated protein kinases in RAGE-mediated nuclear factorkappaB transcriptional activation and cytokine secretion. Diabetes, 50(6), 1495-504 (2001) (Pubitemid 32500185)
29. B. I. Hudson, A. Z. Kalea, M. D. Arriero, E. Harja, E. Boulanger, V. D'Agati, and A. M. Schmidt. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J Biol Chem, 283( 34457-68 (2008)
30. S. Zeng, H. Dun, N. Ippagunta, R. Rosario, Q. Y. Zhang, J. Lefkowitch, S. F. Yan, A. M. Schmidt, and J. C. Emond. Receptor for advanced glycation end product (RAGE)- dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. J Hepatol, 50(5), 929-36 (2009)
31. K. Ishihara, K. Tsutsumi, S. Kawane, M. Nakajima, and T. Kasaoka. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Lett, 550( 107-13 (2003) (Pubitemid 37281366)
32. A. Taguchi, D. C. Blood, G. del Toro, A. Canet, D. C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, M. A. Hofmann, T. Kislinger, M. Ingram, A. Lu, H. Tanaka, O. Hori, S. Ogawa, D. Stern, and A. M. Schmidt. Blockage of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature, 405( 354-60 (2000) (Pubitemid 30337069)
33. J. Xie, D. S. Burz, W. He, I. B. Bronstein, I. Lednev, and A. Shekhtman. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J Biol Chem, 282(6), 4218-31 (2007) (Pubitemid 47084493)
34. T. Ostendorp, E. Leclerc, A. Galichet, M. Koch, N. Demling, B. Weigle, C. W. Heizmann, P. M. Kroneck, and G. Fritz. Structural and functional insights into RAGE activation by multimeric S100B. EMBO J, 26(16), 3868-78 (2007) (Pubitemid 47295872)
35. H. Zong, A. Madden, M. Ward, M. H. Mooney, C. T. Elliott, and A. W. Stitt. Homodimerization is essential for the receptor for advanced glycation end products (RAGE)- mediated signal transduction. J Biol Chem, 285(30), 23137-46 (2010)
36. H. Vissing, L. Aagaard, N. Tommerup, and E. Boel. Localization of the human gene for advanced glycosylation end product-specific receptor (AGER) to chromosome 6p21.3. Genomics, 24(3), 606-8 (1994)
37. J. A. Traherne. Human MHC architecture and evolution: implications for disease association studies. Int J Immunogenet, 35(3), 179-92 (2008) (Pubitemid 351678693)
38. B. I. Hudson, M. H. Stickland, P. J. Grant, and T. S. Futers. Characterization of Allelic and Nucleotide Variation Between the RAGE Gene on Chromosome 6 and a Homologous Pseudogene Sequence to Its 5′ Regulatory Region on Chromosome 3: Implications for Polymorphic Studies in Diabetes. Diabetes, 50(12), 2646-51 (2001) (Pubitemid 33733113)
39. B. I. Hudson, M. H. Stickland, and P. J. Grant. Identification of polymorphisms in the receptor for advanced glycation end-products (RAGE) gene: Prevalence in type II diabetes mellitus and ethnic groups. Diabetes, 47( 1155-7 (1998) (Pubitemid 28294561)
40. B. I. Hudson, M. H. Stickland, T. S. Futers, and P. J. Grant. Effects of novel polymorphisms in the RAGE geneon transcriptional regulation and their association with diabetic retinopathy. Diabetes, 50( 1505-11 (2001) (Pubitemid 32500186)
41. K. Kankova, J. Zahejsky, I. Marova, J. Muzik, V. Kuhrova, M. Blazkova, V. Znojil, M. Beranek, and J. Vacha. Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM. Journal of Diabetes and Its Complications, 15(4), 185-92 (2001) (Pubitemid 33714178)
42. K. Pettersson-Fernholm, C. Forsblom, B. I. Hudson, M. Perola, P. J. Grant, and P. H. Groop. The Functional -374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic Patients. Diabetes, 52(3), 891-4 (2003) (Pubitemid 36323601)
43. C. Falcone, I. Campo, E. Emanuele, M. P. Buzzi, M. Zorzetto, I. Sbarsi, and M. Cuccia. Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease. Int J Mol Med, 14(6), 1061-4 (2004)
44. K. G. dos Santos, L. H. Canani, J. L. Gross, B. Tschiedel, K. E. Pires Souto, and I. Roisenberg. The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol Genet Metab, 85(2), 149-56 (2005) (Pubitemid 40724541)
45. R. Y. Zee, J. R. Romero, J. L. Gould, D. A. Ricupero, and P. M. Ridker. Polymorphisms in the advanced glycosylation end product-specific receptor gene and risk of incident myocardial infarction or ischemic stroke. Stroke, 37(7), 1686-90 (2006) (Pubitemid 44297713)
46. C. Falcone, D. Geroldi, M. P. Buzzi, E. Emanuele, Y. Yilmaz, J. M. Fontana, L. Vignali, C. Boiocchi, I. Sbarsi, and M. Cuccia. The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. Arch Med Res, 39(3), 320-5 (2008)
47. G. Picheth, C. O. Costantini, F. O. Pedrosa, M. T. Leme da Rocha, and S. E. Maltempi de. The -374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients. Clin Chem Lab Med, 45(10), 1268-72 (2007) (Pubitemid 47557065)
48. E. Wang and F. Cambi. Heterogeneous nuclear ribonucleoproteins H and F regulate the proteolipid protein/DM20 ratio by recruiting U1 small nuclear ribonucleoprotein through a complex array of G runs. J Biol Chem, 284(17), 11194-204 (2009)
49. D. B. Hancock, M. Eijgelsheim, J. B. Wilk, S. A. Gharib, L. R. Loehr, K. D. Marciante, N. Franceschini, Y. M. van Durme, T. H. Chen, R. G. Barr, M. B. Schabath, D. J. Couper, G. G. Brusselle, B. M. Psaty, C. M. van Duijn, J. I. Rotter, A. G. Uitterlinden, A. Hofman, N. M. Punjabi, F. Rivadeneira, A. C. Morrison, P. L. Enright, K. E. North, S. R. Heckbert, T. Lumley, B. H. Stricker, G. T. O'Connor, and S. J. London. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet, 42(1), 45-52 (2010)
50. E. Repapi, I. Sayers, L. V. Wain, P. R. Burton, T. Johnson, M. Obeidat, J. H. Zhao, A. Ramasamy, G. Zhai, V. Vitart, J. E. Huffman, W. Igl, E. Albrecht, P. Deloukas, J. Henderson, R. Granell, W. L. McArdle, A. R. Rudnicka, I. Barroso, R. J. Loos, N. J. Wareham, L. Mustelin, T. Rantanen, I. Surakka, M. Imboden, H. E. Wichmann, I. Grkovic, S. Jankovic, L. Zgaga, A. L. Hartikainen, L. Peltonen, U. Gyllensten, A. Johansson, G. Zaboli, H. Campbell, S. H. Wild, J. F. Wilson, S. Glaser, G. Homuth, H. Volzke, M. Mangino, N. Soranzo, T. D. Spector, O. Polasek, I. Rudan, A. F. Wright, M. Heliovaara, S. Ripatti, A. Pouta, A. T. Naluai, A. C. Olin, K. Toren, M. N. Cooper, A. L. James, L. J. Palmer, A. D. Hingorani, S. G. Wannamethee, P. H. Whincup, G. D. Smith, S. Ebrahim, T. M. McKeever, I. D. Pavord, A. K. MacLeod, A. D. Morris, D. J. Porteous, C. Cooper, E. Dennison, S. Shaheen, S. Karrasch, E. Schnabel, H. Schulz, H. Grallert, N. Bouatia-Naji, J. Delplanque, P. Froguel, J. D. Blakey, J. R. Britton, R. W. Morris, J. W. Holloway, D. A. Lawlor, J. Hui, F. Nyberg, M. R. Jarvelin, C. Jackson, M. Kahonen, J. Kaprio, N. M. Probst-Hensch, B. Koch, C. Hayward, D. M. Evans, P. Elliott, D. P. Strachan, I. P. Hall, and M. D. Tobin. Genomewide association study identifies five loci associated with lung function. Nat Genet, 42(1), 36-44 (2010)
51. T. A. Ayoubi and d. Van, V. Regulation of gene expression by alternative promoters. FASEB J, 10(4), 453-60 (1996) (Pubitemid 26120320)
52. J. Li and A. M. Schmidt. Characterisation and functional analysis of the promoter of RAGE, the Receptor for Advanced Glycation End Products. J Biol Chem, 272(26), 16498-506 (1997) (Pubitemid 27276477)
53. P. Schraml, I. Bendik, and C. U. Ludwig. Differential messenger rna and protein expression of the receptor for advanced glycosylated end products in normal lung and nonsmall cell lung carcinoma. Cancer Res, 57( 3669-71 (1997) (Pubitemid 27381205)
54. C. S. Lutz. Alternative polyadenylation: a twist on mRNA 3′ end formation. ACS Chem Biol, 3(10), 609-17 (2008)
55. T. Zhang, V. Kruys, G. Huez, and C. Gueydan. AU-rich element-mediated translational control: complexity and multiple activities of trans-activating factors. Biochem Soc Trans, 30(Pt 6), 952-8 (2002) (Pubitemid 36002387)
56. J. J. Caballero, M. D. Giron, A. M. Vargas, N. Sevillano, M. D. Suarez, and R. Salto. AU-rich elements in the mRNA 3′- untranslated region of the rat receptor for advanced glycation end products and their relevance to mRNA stability. Biochem Biophys Res Commun, 319(1), 247-55 (2004) (Pubitemid 38670187)
57. P. Malherbe, J. G. Richards, H. Gaillard, A. Thompson, C. Diener, A. Schuler, and G. Huber. cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells coexpressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein. Brain Res Mol Brain Res, 71(2), 159-70 (1999) (Pubitemid 29492960)
58. H. Yonekura, Y. Yamamoto, S. Sakurai, R. G. Petrova, M. J. Abedin, H. Li, K. Yasui, M. Takeuchi, Z. Makita, S. Takasawa, H. Okamoto, T. Watanabe, and H. Yamamoto. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J, 370(Pt 3), 1097-109 (2003) (Pubitemid 36399105)
59. C. Schlueter, S. Hauke, A. M. Flohr, P. Rogalla, and J. Bullerdiek. Tissue-specific expression patterns of the RAGE receptor and its soluble forms-a result of regulated alternative splicing? Biochim Biophys Acta, 1630(1), 1-6 (2003) (Pubitemid 37297971)
60. I. H. Park, S. I. Yeon, J. H. Youn, J. E. Choi, N. Sasaki, I. H. Choi, and J. S. Shin. Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells. Mol Immunol, 40(16), 1203-11 (2004) (Pubitemid 38210272)
61. A. Z. Kalea, N. Reiniger, H. Yang, M. Arriero, A. M. Schmidt, and B. I. Hudson. Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. FASEB J, 23(6), 1766-74 (2009)
62. K. A. Sterenczak, S. Willenbrock, M. Barann, M. Klemke, J. T. Soller, N. Eberle, I. Nolte, J. Bullerdiek, and E. H. Murua. Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms. Gene, 434(1-2), 35-42 (2009)
63. A. Harashima, Y. Yamamoto, C. Cheng, K. Tsuneyama, K. M. Myint, A. Takeuchi, K. Yoshimura, H. Li, T. Watanabe, S. Takasawa, H. Okamoto, H. Yonekura, and H. Yamamoto. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation endproducts: structure, function and expression. Biochem J, 396(1), 109-15 (2006) (Pubitemid 43764502)
64. J. A. Holbrook, G. Neu-Yilik, M. W. Hentze, and A. E. Kulozik. Nonsense-mediated decay approaches the clinic. Nat Genet, 36(8), 801-8 (2004) (Pubitemid 39014096)
65. S. A. Hope and I. T. Meredith. Cellular adhesion molecules and cardiovascular disease. Part I. Their expression and role in atherogenesis. Intern Med J, 33(8), 380-6 (2003) (Pubitemid 37082800)
66. J. L. Wautier, C. Zoukourian, O. Chappey, M. P. Wautier, P. J. Guillausseau, R. Cao, O. Hori, D. Stern, and A. M. Schmidt. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest, 97(1), 238-43 (1996)
67. L. Park, K. G. Raman, K. J. Lee, Y. Lu, L. J. Ferran, W. S. Chow, D. Stern, and A. M. Schmidt. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med, 4(9), 1025-31 (1998) (Pubitemid 28417334)
68. L. G. Bucciarelli, T. Wendt, W. Qu, Y. Lu, E. Lalla, L. L. Rong, M. T. Goova, B. Moser, T. Kislinger, D. C. Lee, Y. Kashyap, D. M. Stern, and A. M. Schmidt. RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E-Null Mice. Circulation, 106(22), 2827-35 (2002) (Pubitemid 35396983)
69. T. Wendt, E. Harja, L. Bucciarelli, W. Qu, Y. Lu, L. L. Rong, D. G. Jenkins, G. Stein, A. M. Schmidt, and S. F. Yan. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis, 185(1), 70-7 (2006) (Pubitemid 43117552)
70. A. Z. Kalea, F. See, E. Harja, M. Arriero, A. M. Schmidt, and B. I. Hudson. Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling. Cancer Res, 70(13), 5628-38 (2010)
71. T. Shoji, H. Koyama, T. Morioka, S. Tanaka, A. Kizu, K. Motoyama, K. Mori, S. Fukumoto, A. Shioi, N. Shimogaito, M. Takeuchi, Y. Yamamoto, H. Yonekura, H. Yamamoto, and Y. Nishizawa. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes, 55(8), 2245-55 (2006) (Pubitemid 44743621)
72. K. Ohe, T. Watanabe, S. Harada, S. Munesue, Y. Yamamoto, H. Yonekura, and H. Yamamoto. Regulation of alternative splicing of the receptor for advanced glycation endproducts (RAGE) through G-rich cis-elements and heterogenous nuclear ribonucleoprotein H. J Biochem, 147(5), 651-9 (2010)
73. M. C. Schaub, S. R. Lopez, and M. Caputi. Members of the heterogeneous nuclear ribonucleoprotein H family activate splicing of an HIV-1 splicing substrate by promoting formation of ATP-dependent spliceosomal complexes. J Biol Chem, 282(18), 13617-26 (2007) (Pubitemid 47100498)
74. A. M. Krecic and M. S. Swanson. hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol, 11(3), 363-71 (1999) (Pubitemid 29273808)
75. H. L. Tam, S. W. Shiu, Y. Wong, W. S. Chow, D. J. Betteridge, and K. C. Tan. Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes. Atherosclerosis, 209(1), 173-7 (2010)
76. K. C. Tan, W. S. Chow, A. W. Tso, A. Xu, H. F. Tse, R. L. Hoo, D. J. Betteridge, and K. S. Lam. Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes. Diabetologia, 50(9), 1819-25 (2007) (Pubitemid 47222871)
77. M. L. Heaney and D. W. Golde. Soluble receptors in human disease. J Leukoc Biol, 64(2), 135-46 (1998) (Pubitemid 28354974)
78. S. Sakurai, Y. Yamamoto, H. Tamei, H. Matsuki, K. Obata, L. Hui, J. Miura, M. Osawa, Y. Uchigata, Y. Iwamoto, T. Watanabe, H. Yonekura, and H. Yamamoto. Development of an ELISA for esRAGE and its application to type 1 diabetic patients. Diabetes Res Clin Pract, 73(2), 158-65 (2006) (Pubitemid 43928158)
79. A. Raucci, S. Cugusi, A. Antonelli, S. M. Barabino, L. Monti, A. Bierhaus, K. Reiss, P. Saftig, and M. E. Bianchi. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J, 22( 3716-27 (2008)
80. A. Galichet, M. Weibel, and C. W. Heizmann. Calciumregulated intramembrane proteolysis of the RAGE receptor. Biochem Biophys Res Commun, 370(1), 1-5 (2008)
81. L. Zhang, M. Bukulin, E. Kojro, A. Roth, V. V. Metz, F. Fahrenholz, P. P. Nawroth, A. Bierhaus, and R. Postina. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J Biol Chem, 283(51), 35507-16 (2008)
82. L. E. Hanford, J. J. Enghild, Z. Valnickova, S. V. Petersen, L. M. Schaefer, T. M. Schaefer, T. A. Reinhart, and T. D. Oury. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem, 279(48), 50019-24 (2004) (Pubitemid 39577812)
83. P. M. Humpert, G. Papadopoulos, K. Schaefer, Z. Djuric, I. Konrade, M. Morcos, P. P. Nawroth, and A. Bierhaus. sRAGE and esRAGE are not associated with peripheral or autonomic neuropathy in type 2 diabetes. Horm Metab Res, 39(12), 899-902 (2007)
84. N. Katakami, M. Matsuhisa, H. Kaneto, T. A. Matsuoka, K. Sakamoto, T. Yasuda, and Y. Yamasaki. Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients. Diab Vasc Dis Res, 5(3), 190-7 (2008)
85. C. Falcone, E. Emanuele, A. D'Angelo, M. P. Buzzi, C. Belvito, M. Cuccia, and D. Geroldi. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol, 25(5), 1032-7 (2005) (Pubitemid 40627851)
86. D. Geroldi, C. Falcone, E. Emanuele, A. D'Angelo, M. Calcagnino, M. P. Buzzi, G. A. Scioli, and R. Fogari. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J Hypertens, 23(9), 1725-9 (2005) (Pubitemid 41233433)
87. N. Katakami, M. Matsuhisa, H. Kaneto, T. A. Matsuoka, K. Sakamoto, T. Yasuda, Y. Umayahara, K. Kosugi, and Y. Yamasaki. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes. Atherosclerosis, 204( 288-92 (2009)
88. F. Santilli, L. Bucciarelli, D. Noto, A. B. Cefalu, V. Davi, E. Ferrante, C. Pettinella, M. R. Averna, G. Ciabattoni, and G. Davi. Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. Free Radic Biol Med, 43(9), 1255-62 (2007) (Pubitemid 47429934)
89. E. Emanuele, A. D'Angelo, C. Tomaino, G. Binetti, R. Ghidoni, P. Politi, L. Bernardi, R. Maletta, A. C. Bruni, and D. Geroldi. Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch Neurol, 62(11), 1734-6 (2005) (Pubitemid 41626671)
90. Y. Yilmaz, E. Ulukaya, O. O. Gul, M. Arabul, C. B. Gul, O. Atug, A. Y. Oral, S. Aker, and E. Dolar. Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease. Clin Biochem, 42(9), 802-7 (2009)
91. J. Steiner, M. Walter, M. T. Wunderlich, H. G. Bernstein, B. Panteli, M. Brauner, R. Jacobs, T. Gos, M. Rothermundt, and B. Bogerts. A new pathophysiological aspect of S100B in schizophrenia: potential regulation of S100B by its scavenger soluble RAGE. Biol Psychiatry, 65(12), 1107-10 (2009)
92. G. Basta, A. M. Sironi, G. Lazzerini, T. S. Del, E. Buzzigoli, A. Casolaro, A. Natali, E. Ferrannini, and A. Gastaldelli. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. J Clin Endocrinol Metab, 91(11), 4628-34 (2006) (Pubitemid 44833448)
93. D. Geroldi, C. Falcone, P. Minoretti, E. Emanuele, M. Arra, and A. D'Angelo. High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans. J Am Geriatr Soc, 54(7), 1149-50 (2006) (Pubitemid 43992560)
94. H. Koyama, T. Shoji, H. Yokoyama, K. Motoyama, K. Mori, S. Fukumoto, M. Emoto, T. Shoji, H. Tamei, H. Matsuki, S. Sakurai, Y. Yamamoto, H. Yonekura, T. Watanabe, H. Yamamoto, and Y. Nishizawa. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol, 25(12), 2587-93 (2005) (Pubitemid 43732283)
95. K. M. Choi, H. J. Yoo, H. Y. Kim, K. W. Lee, J. A. Seo, S. G. Kim, N. H. Kim, D. S. Choi, and S. H. Baik. Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness. Int J Cardiol, 132( 96-101 (2009)
96. R. D. Semba, L. Ferrucci, K. Sun, J. Beck, M. Dalal, R. Varadhan, J. Walston, J. M. Guralnik, and L. P. Fried. Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women. Aging Clin Exp Res, 21(2), 182-90 (2009)
97. R. D. Semba, L. Ferrucci, K. Sun, K. V. Patel, J. M. Guralnik, and L. P. Fried. Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women. Age Ageing, 38(3), 283-9 (2009)
98. M. Boso, E. Emanuele, P. Minoretti, M. Arra, P. Politi, N. S. Ucelli di, and F. Barale. Alterations of circulating endogenous secretory RAGE and S100A9 levels indicating dysfunction of the AGE-RAGE axis in autism. Neurosci Lett, 410(3), 169-73 (2006) (Pubitemid 44750339)
99. A. Takeuchi, Y. Yamamoto, K. Tsuneyama, C. Cheng, H. Yonekura, T. Watanabe, K. Shimizu, K. Tomita, H. Yamamoto, and H. Tsuchiya. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma. Cancer, 109(12), 2532-40 (2007) (Pubitemid 46906473)
100. R. D. Semba, L. Ferrucci, J. C. Fink, K. Sun, J. Beck, M. Dalal, J. M. Guralnik, and L. P. Fried. Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women. Am J Kidney Dis, 53(1), 51-8 (2009)
101. J. Kyte and R. F. Doolittle. A simple method for displaying the hydropathic character of a protein. J Mol Biol, 157(1), 105-32 (1982)